Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F5CET
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,453
Award facts
- Contract value 100% obligated
- $1,453.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $1,453.09 delivery order to Amerisourcebergen Drug Corp on July 15, 2026, for XYOSTED 75 MG/0.5 ML auto-injector (testosterone replacement therapy) with an ultimate completion date of July 16, 2026.
Place of performance is Conshohocken, PA. The order is priced as firm fixed-price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F5CET?
SPE2DR26F5CET was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 15, 2026.
How much is contract SPE2DR26F5CET worth?
The government has obligated $1,453 on SPE2DR26F5CET.
Is contract SPE2DR26F5CET an order under another contract?
Yes. SPE2DR26F5CET is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F5CET competed?
The extent of competition for SPE2DR26F5CET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award